Compare Iron Mountain Inc (IRM) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iron Mountain Inc vs Recursion Pharmaceuticals Inc — how do they compare? Iron Mountain Inc trades at $122.41 (market cap $36.44B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Iron Mountain Inc is far larger — about 20.1× Recursion Pharmaceuticals Inc's market cap, and Iron Mountain Inc pays a 2.82% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| IRM | RXRX | |
|---|---|---|
Market Cap | $36.44B | $1.81B |
Sector | Real Estate | Health |
52-Week High | $133.06 | $6.79 |
52-Week Low | $78.86 | $2.84 |
Enterprise Value | $55.85B | $1.33B |
Dividend Yield | 2.82% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
